Table 1.
Patient characters of BG groups.
| Proven PCP (n = 24) | Probable PCP (n = 155) | Negative PCP (n = 50) | |
|---|---|---|---|
| Male/female ratio | 1:1 | 1.21:1 | 1.53:1 |
| Age (years), media (range) | 50 (21–83) | 50 (15–83) | 59(18–84) |
| Biological samples type | |||
| Bronchoalveolar lavage fluids (n, %) | 10 (41.67) | 40 (25.81) | 21 (42.00) |
| Induced sputa (n, %) | 14 (58.33) | 115 (74.19) | 29 (58.00) |
| Underlying condition | |||
| SLE (n, %) | 5 (20.83) | 18 (11.61) | – |
| non-SLE RID (n, %) | 10 (41.67) | 54 (34.84) | – |
| Hematological malignancy (n, %) | 2 (8.33) | 8 (5.16) | – |
| Others (n, %) | 7 (29.17) | 75 (48.39) | – |
| Outcome of PCP | |||
| LOH (days), media (range) | 25 (3–80) | 24 (2–101) | – |
| ICU (n, %) | 11 (45.83) | 78 (50.32) | – |
| 30-day mortality, (n, %) | 6 (25.00) | 28 (18.10) | – |
SLE systemic lupus erythematosus, RIG rheumatic immunity diseases, LOH length of hospitalization, ICU intensive care unit.